Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Trends in Pharmacological Sciences|May 1, 2022
SEAKER cells coordinate cellular immunotherapy with localized chemotherapyIsabel C Lane, Max JanCell Stem Cell|March 8, 2026
Off-the-shelf CAR natural killer progenitor cell therapies are built to lastNoor Radde, Max JanLeukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.Seminars in Hematology|January 17, 2017
Clonal hematopoiesisMax Jan, Benjamin L Ebert, Siddhartha JaiswalNature Reviews. Clinical Oncology|March 3, 2021
Cancer therapies based on targeted protein degradation - lessons learned with lenalidomideMax Jan, Adam S Sperling, Benjamin L EbertCell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.Trends in Cancer|February 14, 2024
Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunologyGabriele J Kembuan, Joanna Y Kim, Marcela V Maus, et al.Journal of Pathology Informatics|February 28, 2015
Development and validation of an app-based cell counter for use in the clinical laboratory settingAlexander C Thurman, Jessica L Davis, Max Jan, et al.Proceedings of the National Academy of Sciences of the United States of America|March 9, 2011
Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell markerMax Jan, Mark P Chao, Adriel C Cha, et al.Science Translational Medicine|August 31, 2012
Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemiaMax Jan, Thomas M Snyder, M Ryan Corces-Zimmerman, et al.Pageof 3